Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The global ventral hernia treatment market garnered a market value of US$ 4.75 billion in 2022 and is expected to accumulate a market value of US$ 9.4 billion by registering a CAGR of 6.4% in the forecast period 2023 to 2033. The growth of the ventral hernia treatment market can be attributed to the increasing incidence of ventral hernias, the rising demand for minimally invasive surgical procedures, the growing geriatric population, and the availability of technologically advanced products and services. The market for ventral hernia treatment registered a CAGR of 3.3% in the historical period 2018 to 2022
A ventral hernia is a condition where a portion of the intestines or other abdominal tissue pushes through a weakened area of the abdominal muscles, causing a bulge or protrusion on the skin's surface.
The treatment of ventral hernias includes surgical procedures like laparoscopic surgery, open surgery, and other minimally invasive techniques. The market for ventral hernia treatment includes medical devices, surgical equipment, pharmaceuticals, and other related products and services used in the diagnosis, treatment, and management of ventral hernias.
Report Attribute | Details |
---|---|
Expected Market Value (2023) | US$ 5.05 Billion |
Anticipated Forecast Value (2033) | US$ 9.4 Billion |
Projected Growth Rate (2023 to 2033) | 6.4% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to market research and competitive intelligence provider Future Market Insights- the market for Ventral hernia treatment reflected a value of 3.3% during the historical period, 2018 to 2022.
The growth was attributed to the increasing prevalence of ventral hernias, the rising demand for minimally invasive surgical procedures, and the availability of advanced hernia repair devices. Moreover, key players have been investing in research and development for innovating novel therapies for ventral hernia treatment. Thus, the market for ventral hernia treatment is expected to register a CAGR of 6.4% in the forecast period 2023 to 2033.
Growing preference for minimally invasive surgical procedures driving market growth
The prevalence of ventral hernias is increasing globally due to several factors such as obesity, aging population, and sedentary lifestyle. This has led to a rise in demand for hernia repair surgeries and related products and services. The development of advanced hernia repair devices such as mesh implants, surgical staplers, and robotic-assisted surgical systems has improved the efficiency and safety of hernia repair surgeries, leading to increased adoption of these devices.
Minimally invasive surgical procedures, such as laparoscopic surgery, offer several advantages over traditional open surgeries, including reduced pain, faster recovery, and shorter hospital stays. This has led to a growing preference for minimally invasive procedures among patients and healthcare providers.
Awareness and education campaigns by healthcare organizations and governments have helped to increase public awareness about ventral hernias and their treatment options, leading to increased demand for hernia repair surgeries and related products and services. The increasing healthcare spending globally, particularly in emerging markets, has led to increased access to healthcare services, including hernia repair surgeries and related products and services.
Availability of treatments shaping landscape for ventral hernias treatment market
High cost of treatment along with reimbursement issues derailing market growth for ventral hernia treatment market
The cost of hernia repair surgeries and related products and services can be high, particularly for uninsured or underinsured patients, which can limit access to care. In some countries, reimbursement policies for hernia repair surgeries may be inadequate, which can limit access to care and affect the demand for hernia repair devices and related products and services.
Despite efforts to increase awareness about hernias and their treatment options, many people may still be unaware of the condition, which can delay diagnosis and treatment. Like any surgical procedure, hernia repair surgeries carry risks of complications such as infection, bleeding, and nerve damage.
The ventral hernia treatment market is highly competitive, with several key players operating in the industry, which can make it difficult for new entrants to establish themselves and compete with established players. The ventral hernia treatment market is subject to various regulations and standards, which can affect the development and commercialization of hernia repair devices and related products and services.
Growing preference for minimally invasive surgeries driving market growth in North America
The North American ventral hernia treatment market is a significant market segment within the global hernia treatment market. North America is one of the largest markets for hernia treatment globally, and it includes the United States and Canada.
The increasing prevalence of obesity and an aging population in North America has contributed to the rising incidence of ventral hernias in the region. This, in turn, has led to an increase in demand for hernia repair surgeries and related products and services.
The North America ventral hernia treatment market is highly competitive, with several key players operating in the industry. These companies are investing heavily in research and development to develop advanced hernia repair devices and surgical techniques.
The market is also witnessing a growing preference for minimally invasive surgical procedures, such as laparoscopic surgery, over traditional open surgeries. This trend is driven by the benefits of minimally invasive procedures, including reduced pain, faster recovery, and shorter hospital stays.
Overall, the North America ventral hernia treatment market is expected to continue to grow in the coming years, driven by increasing awareness and education about hernias, advances in hernia repair devices and surgical techniques, and the rising incidence of ventral hernias in the region. Thus, North America is expected to possess a 46% market share for ventral hernia treatment market.
Rising demand for outpatient procedures bolstering growth of ventral hernia treatment market in Europe
The incidence of ventral hernias is increasing in Europe due to factors such as an aging population, sedentary lifestyles, and obesity. This has led to an increase in demand for hernia repair surgeries and related products and services.
The development of new and innovative hernia repair devices and surgical techniques is driving growth in the Europe ventral hernia treatment market. For example, the use of minimally invasive laparoscopic surgery techniques is increasing in popularity, as it is associated with faster recovery times and reduced pain compared to traditional open surgery.
There is a growing trend towards outpatient hernia repair surgeries in Europe. Outpatient surgeries are less expensive and more convenient for patients, which is driving growth in the ventral hernia treatment market. Many countries in Europe have favorable reimbursement policies for hernia repair surgeries, which is helping to drive growth in the ventral hernia treatment market.
There is growing awareness and education about hernias and their treatment options among healthcare providers and the general public in Europe, which is driving demand for hernia repair products and services. Thus, Europe is expected to possess a 38% market share for ventral hernia treatment market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Availability of specialized medical staff maximizing the use of hospitals for ventral hernia treatment
Hospitals have a team of specialized medical staff, including surgeons, anesthesiologists, and nurses, who are trained and experienced in treating ventral hernias. These healthcare professionals have the necessary skills and knowledge to provide effective hernia treatment and manage any complications that may arise during or after the procedure.
Hospitals are equipped with advanced technology and equipment that are necessary for performing hernia surgeries safely and effectively. This includes surgical instruments, imaging technology, and monitoring devices that help ensure the patient's safety and well-being during the procedure.
After hernia surgery, patients require ongoing care and monitoring to ensure proper healing and prevent complications. Hospitals provide a range of post-operative care services, including pain management, wound care, and physical therapy, that can help patients recover more quickly and with fewer complications.
In rare cases, hernia surgery can lead to complications that require emergency medical attention. Hospitals are equipped to handle emergencies and have the necessary resources to provide life-saving care if needed. Thus, hospitals are expected to possess a 48% market share for ventral hernia treatment market.
Key players in the ventral hernia treatment market are Medtronic, Becton Dickinson & Company, Braun Melsungen AG, Cook Medical Inc., Cooper Companies Inc., Baxter International, Inc., Integra LifeSciences, W.L. Gore & Associates, AbbVie, Johnson & Johnson Services, Inc.
Report Attribute | Details |
---|---|
Market Value in 2023 | US$ 5.05 Billion |
Market Value in 2033 | US$ 9.4 Billion |
Growth Rate | CAGR of 6.4% from 2023 to 2033 |
Base Year for Estimation | 2022 |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | Revenue in USD Billion and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
The industry is valued at US$ 5.05 billion in 2023.
Ethicon, Bard, and Aesculap are key industry players.
The key consumer of the ventral hernia treatment market is the healthcare industry.
The industry is estimated to reach US$ 9.4 billion by 2033.
The ventral hernia treatment market CAGR for 2033 is 6.4%.
1. Executive Summary | Ventral Hernia Treatment Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018-2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033 5.3.1. Epigastric (stomach area) hernia 5.3.2. Umbilical (belly button) hernia 5.3.3. Incisional hernia 5.4. Y-o-Y Growth Trend Analysis By Type, 2018-2022 5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 6. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Diagnosis 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Diagnosis, 2018-2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Diagnosis, 2023 to 2033 6.3.1. Ultrasound 6.3.2. CT scan 6.3.3. MRI 6.4. Y-o-Y Growth Trend Analysis By Diagnosis, 2018-2022 6.5. Absolute $ Opportunity Analysis By Diagnosis, 2023 to 2033 7. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Surgery Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Surgery Type , 2018-2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Surgery Type , 2023 to 2033 7.3.1. Open hernia surgery 7.3.2. Laparoscopic surgery 7.3.3. Robotic hernia surgery 7.4. Y-o-Y Growth Trend Analysis By Surgery Type , 2018-2022 7.5. Absolute $ Opportunity Analysis By Surgery Type , 2023 to 2033 8. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By End-use 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2018-2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2023 to 2033 8.3.1. Hospitals 8.3.2. Ambulatory Surgical Centres 8.3.3. Clinics 8.4. Y-o-Y Growth Trend Analysis By End-use, 2018-2022 8.5. Absolute $ Opportunity Analysis By End-use, 2023 to 2033 9. Global Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Type 10.2.3. By Diagnosis 10.2.4. By Surgery Type 10.2.5. By End-use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Diagnosis 10.3.4. By Surgery Type 10.3.5. By End-use 10.4. Key Takeaways 11. Latin America Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Type 11.2.3. By Diagnosis 11.2.4. By Surgery Type 11.2.5. By End-use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Diagnosis 11.3.4. By Surgery Type 11.3.5. By End-use 11.4. Key Takeaways 12. Europe Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. U.K. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Type 12.2.3. By Diagnosis 12.2.4. By Surgery Type 12.2.5. By End-use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Diagnosis 12.3.4. By Surgery Type 12.3.5. By End-use 12.4. Key Takeaways 13. South Asia Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Malaysia 13.2.1.3. Singapore 13.2.1.4. Thailand 13.2.1.5. Rest of South Asia 13.2.2. By Type 13.2.3. By Diagnosis 13.2.4. By Surgery Type 13.2.5. By End-use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Diagnosis 13.3.4. By Surgery Type 13.3.5. By End-use 13.4. Key Takeaways 14. East Asia Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Type 14.2.3. By Diagnosis 14.2.4. By Surgery Type 14.2.5. By End-use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Diagnosis 14.3.4. By Surgery Type 14.3.5. By End-use 14.4. Key Takeaways 15. Oceania Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. Australia 15.2.1.2. New Zealand 15.2.2. By Type 15.2.3. By Diagnosis 15.2.4. By Surgery Type 15.2.5. By End-use 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Type 15.3.3. By Diagnosis 15.3.4. By Surgery Type 15.3.5. By End-use 15.4. Key Takeaways 16. MEA Ventral Hernia Treatment Market Analysis 2018-2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Type 16.2.3. By Diagnosis 16.2.4. By Surgery Type 16.2.5. By End-use 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Type 16.3.3. By Diagnosis 16.3.4. By Surgery Type 16.3.5. By End-use 16.4. Key Takeaways 17. Key Countries Ventral Hernia Treatment Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Type 17.1.2.2. By Diagnosis 17.1.2.3. By Surgery Type 17.1.2.4. By End-use 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Type 17.2.2.2. By Diagnosis 17.2.2.3. By Surgery Type 17.2.2.4. By End-use 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Type 17.3.2.2. By Diagnosis 17.3.2.3. By Surgery Type 17.3.2.4. By End-use 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Type 17.4.2.2. By Diagnosis 17.4.2.3. By Surgery Type 17.4.2.4. By End-use 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Type 17.5.2.2. By Diagnosis 17.5.2.3. By Surgery Type 17.5.2.4. By End-use 17.6. United kingdom 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Type 17.6.2.2. By Diagnosis 17.6.2.3. By Surgery Type 17.6.2.4. By End-use 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Type 17.7.2.2. By Diagnosis 17.7.2.3. By Surgery Type 17.7.2.4. By End-use 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Type 17.8.2.2. By Diagnosis 17.8.2.3. By Surgery Type 17.8.2.4. By End-use 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Type 17.9.2.2. By Diagnosis 17.9.2.3. By Surgery Type 17.9.2.4. By End-use 17.10. India 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Type 17.10.2.2. By Diagnosis 17.10.2.3. By Surgery Type 17.10.2.4. By End-use 17.11. Malaysia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Type 17.11.2.2. By Diagnosis 17.11.2.3. By Surgery Type 17.11.2.4. By End-use 17.12. Singapore 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Type 17.12.2.2. By Diagnosis 17.12.2.3. By Surgery Type 17.12.2.4. By End-use 17.13. Thailand 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Type 17.13.2.2. By Diagnosis 17.13.2.3. By Surgery Type 17.13.2.4. By End-use 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Type 17.14.2.2. By Diagnosis 17.14.2.3. By Surgery Type 17.14.2.4. By End-use 17.15. Japan 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Type 17.15.2.2. By Diagnosis 17.15.2.3. By Surgery Type 17.15.2.4. By End-use 17.16. South Korea 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Type 17.16.2.2. By Diagnosis 17.16.2.3. By Surgery Type 17.16.2.4. By End-use 17.17. Australia 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Type 17.17.2.2. By Diagnosis 17.17.2.3. By Surgery Type 17.17.2.4. By End-use 17.18. New Zealand 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Type 17.18.2.2. By Diagnosis 17.18.2.3. By Surgery Type 17.18.2.4. By End-use 17.19. GCC Countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Type 17.19.2.2. By Diagnosis 17.19.2.3. By Surgery Type 17.19.2.4. By End-use 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Type 17.20.2.2. By Diagnosis 17.20.2.3. By Surgery Type 17.20.2.4. By End-use 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Type 17.21.2.2. By Diagnosis 17.21.2.3. By Surgery Type 17.21.2.4. By End-use 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Type 18.3.3. By Diagnosis 18.3.4. By Surgery Type 18.3.5. By End-use 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Medtronic 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Becton Dickinson & Company 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. B. Braun Melsungen AG 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Cook Medical Inc. 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Cooper Companies Inc. 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Baxter International, Inc. 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Integra LifeSciences 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. W.L. Gore & Associates 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. AbbVie 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Johnson & Johnson Services, Inc. 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Surgery Type , 2018 to 2033 Table 5: Global Market Value (US$ Million) Forecast by End-use, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033 Table 9: North America Market Value (US$ Million) Forecast by Surgery Type , 2018 to 2033 Table 10: North America Market Value (US$ Million) Forecast by End-use, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 13: Latin America Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033 Table 14: Latin America Market Value (US$ Million) Forecast by Surgery Type , 2018 to 2033 Table 15: Latin America Market Value (US$ Million) Forecast by End-use, 2018 to 2033 Table 16: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 17: Europe Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 18: Europe Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033 Table 19: Europe Market Value (US$ Million) Forecast by Surgery Type , 2018 to 2033 Table 20: Europe Market Value (US$ Million) Forecast by End-use, 2018 to 2033 Table 21: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: South Asia Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 23: South Asia Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033 Table 24: South Asia Market Value (US$ Million) Forecast by Surgery Type , 2018 to 2033 Table 25: South Asia Market Value (US$ Million) Forecast by End-use, 2018 to 2033 Table 26: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 27: East Asia Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 28: East Asia Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033 Table 29: East Asia Market Value (US$ Million) Forecast by Surgery Type , 2018 to 2033 Table 30: East Asia Market Value (US$ Million) Forecast by End-use, 2018 to 2033 Table 31: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 32: Oceania Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 33: Oceania Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033 Table 34: Oceania Market Value (US$ Million) Forecast by Surgery Type , 2018 to 2033 Table 35: Oceania Market Value (US$ Million) Forecast by End-use, 2018 to 2033 Table 36: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 37: MEA Market Value (US$ Million) Forecast by Type, 2018 to 2033 Table 38: MEA Market Value (US$ Million) Forecast by Diagnosis, 2018 to 2033 Table 39: MEA Market Value (US$ Million) Forecast by Surgery Type , 2018 to 2033 Table 40: MEA Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Diagnosis, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Surgery Type , 2023 to 2033 Figure 4: Global Market Value (US$ Million) by End-use, 2023 to 2033 Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 9: Global Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 10: Global Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 11: Global Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 12: Global Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033 Figure 13: Global Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033 Figure 14: Global Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033 Figure 15: Global Market Value (US$ Million) Analysis by Surgery Type , 2018 to 2033 Figure 16: Global Market Value Share (%) and BPS Analysis by Surgery Type , 2023 to 2033 Figure 17: Global Market Y-o-Y Growth (%) Projections by Surgery Type , 2023 to 2033 Figure 18: Global Market Value (US$ Million) Analysis by End-use, 2018 to 2033 Figure 19: Global Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033 Figure 20: Global Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033 Figure 21: Global Market Attractiveness by Type, 2023 to 2033 Figure 22: Global Market Attractiveness by Diagnosis, 2023 to 2033 Figure 23: Global Market Attractiveness by Surgery Type , 2023 to 2033 Figure 24: Global Market Attractiveness by End-use, 2023 to 2033 Figure 25: Global Market Attractiveness by Region, 2023 to 2033 Figure 26: North America Market Value (US$ Million) by Type, 2023 to 2033 Figure 27: North America Market Value (US$ Million) by Diagnosis, 2023 to 2033 Figure 28: North America Market Value (US$ Million) by Surgery Type , 2023 to 2033 Figure 29: North America Market Value (US$ Million) by End-use, 2023 to 2033 Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 37: North America Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033 Figure 38: North America Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033 Figure 39: North America Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033 Figure 40: North America Market Value (US$ Million) Analysis by Surgery Type , 2018 to 2033 Figure 41: North America Market Value Share (%) and BPS Analysis by Surgery Type , 2023 to 2033 Figure 42: North America Market Y-o-Y Growth (%) Projections by Surgery Type , 2023 to 2033 Figure 43: North America Market Value (US$ Million) Analysis by End-use, 2018 to 2033 Figure 44: North America Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033 Figure 45: North America Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033 Figure 46: North America Market Attractiveness by Type, 2023 to 2033 Figure 47: North America Market Attractiveness by Diagnosis, 2023 to 2033 Figure 48: North America Market Attractiveness by Surgery Type , 2023 to 2033 Figure 49: North America Market Attractiveness by End-use, 2023 to 2033 Figure 50: North America Market Attractiveness by Country, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) by Type, 2023 to 2033 Figure 52: Latin America Market Value (US$ Million) by Diagnosis, 2023 to 2033 Figure 53: Latin America Market Value (US$ Million) by Surgery Type , 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) by End-use, 2023 to 2033 Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 59: Latin America Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 62: Latin America Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033 Figure 65: Latin America Market Value (US$ Million) Analysis by Surgery Type , 2018 to 2033 Figure 66: Latin America Market Value Share (%) and BPS Analysis by Surgery Type , 2023 to 2033 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Surgery Type , 2023 to 2033 Figure 68: Latin America Market Value (US$ Million) Analysis by End-use, 2018 to 2033 Figure 69: Latin America Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033 Figure 71: Latin America Market Attractiveness by Type, 2023 to 2033 Figure 72: Latin America Market Attractiveness by Diagnosis, 2023 to 2033 Figure 73: Latin America Market Attractiveness by Surgery Type , 2023 to 2033 Figure 74: Latin America Market Attractiveness by End-use, 2023 to 2033 Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 76: Europe Market Value (US$ Million) by Type, 2023 to 2033 Figure 77: Europe Market Value (US$ Million) by Diagnosis, 2023 to 2033 Figure 78: Europe Market Value (US$ Million) by Surgery Type , 2023 to 2033 Figure 79: Europe Market Value (US$ Million) by End-use, 2023 to 2033 Figure 80: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 84: Europe Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 85: Europe Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 86: Europe Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 87: Europe Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033 Figure 88: Europe Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033 Figure 89: Europe Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033 Figure 90: Europe Market Value (US$ Million) Analysis by Surgery Type , 2018 to 2033 Figure 91: Europe Market Value Share (%) and BPS Analysis by Surgery Type , 2023 to 2033 Figure 92: Europe Market Y-o-Y Growth (%) Projections by Surgery Type , 2023 to 2033 Figure 93: Europe Market Value (US$ Million) Analysis by End-use, 2018 to 2033 Figure 94: Europe Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033 Figure 95: Europe Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033 Figure 96: Europe Market Attractiveness by Type, 2023 to 2033 Figure 97: Europe Market Attractiveness by Diagnosis, 2023 to 2033 Figure 98: Europe Market Attractiveness by Surgery Type , 2023 to 2033 Figure 99: Europe Market Attractiveness by End-use, 2023 to 2033 Figure 100: Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: South Asia Market Value (US$ Million) by Type, 2023 to 2033 Figure 102: South Asia Market Value (US$ Million) by Diagnosis, 2023 to 2033 Figure 103: South Asia Market Value (US$ Million) by Surgery Type , 2023 to 2033 Figure 104: South Asia Market Value (US$ Million) by End-use, 2023 to 2033 Figure 105: South Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 106: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 107: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 108: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 109: South Asia Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 110: South Asia Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 111: South Asia Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 112: South Asia Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033 Figure 113: South Asia Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033 Figure 114: South Asia Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033 Figure 115: South Asia Market Value (US$ Million) Analysis by Surgery Type , 2018 to 2033 Figure 116: South Asia Market Value Share (%) and BPS Analysis by Surgery Type , 2023 to 2033 Figure 117: South Asia Market Y-o-Y Growth (%) Projections by Surgery Type , 2023 to 2033 Figure 118: South Asia Market Value (US$ Million) Analysis by End-use, 2018 to 2033 Figure 119: South Asia Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033 Figure 120: South Asia Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033 Figure 121: South Asia Market Attractiveness by Type, 2023 to 2033 Figure 122: South Asia Market Attractiveness by Diagnosis, 2023 to 2033 Figure 123: South Asia Market Attractiveness by Surgery Type , 2023 to 2033 Figure 124: South Asia Market Attractiveness by End-use, 2023 to 2033 Figure 125: South Asia Market Attractiveness by Country, 2023 to 2033 Figure 126: East Asia Market Value (US$ Million) by Type, 2023 to 2033 Figure 127: East Asia Market Value (US$ Million) by Diagnosis, 2023 to 2033 Figure 128: East Asia Market Value (US$ Million) by Surgery Type , 2023 to 2033 Figure 129: East Asia Market Value (US$ Million) by End-use, 2023 to 2033 Figure 130: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 131: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 132: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 134: East Asia Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 135: East Asia Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 137: East Asia Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033 Figure 138: East Asia Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033 Figure 139: East Asia Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033 Figure 140: East Asia Market Value (US$ Million) Analysis by Surgery Type , 2018 to 2033 Figure 141: East Asia Market Value Share (%) and BPS Analysis by Surgery Type , 2023 to 2033 Figure 142: East Asia Market Y-o-Y Growth (%) Projections by Surgery Type , 2023 to 2033 Figure 143: East Asia Market Value (US$ Million) Analysis by End-use, 2018 to 2033 Figure 144: East Asia Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033 Figure 145: East Asia Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033 Figure 146: East Asia Market Attractiveness by Type, 2023 to 2033 Figure 147: East Asia Market Attractiveness by Diagnosis, 2023 to 2033 Figure 148: East Asia Market Attractiveness by Surgery Type , 2023 to 2033 Figure 149: East Asia Market Attractiveness by End-use, 2023 to 2033 Figure 150: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 151: Oceania Market Value (US$ Million) by Type, 2023 to 2033 Figure 152: Oceania Market Value (US$ Million) by Diagnosis, 2023 to 2033 Figure 153: Oceania Market Value (US$ Million) by Surgery Type , 2023 to 2033 Figure 154: Oceania Market Value (US$ Million) by End-use, 2023 to 2033 Figure 155: Oceania Market Value (US$ Million) by Country, 2023 to 2033 Figure 156: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 157: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 158: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 159: Oceania Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 160: Oceania Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 161: Oceania Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 162: Oceania Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033 Figure 163: Oceania Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033 Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033 Figure 165: Oceania Market Value (US$ Million) Analysis by Surgery Type , 2018 to 2033 Figure 166: Oceania Market Value Share (%) and BPS Analysis by Surgery Type , 2023 to 2033 Figure 167: Oceania Market Y-o-Y Growth (%) Projections by Surgery Type , 2023 to 2033 Figure 168: Oceania Market Value (US$ Million) Analysis by End-use, 2018 to 2033 Figure 169: Oceania Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033 Figure 170: Oceania Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033 Figure 171: Oceania Market Attractiveness by Type, 2023 to 2033 Figure 172: Oceania Market Attractiveness by Diagnosis, 2023 to 2033 Figure 173: Oceania Market Attractiveness by Surgery Type , 2023 to 2033 Figure 174: Oceania Market Attractiveness by End-use, 2023 to 2033 Figure 175: Oceania Market Attractiveness by Country, 2023 to 2033 Figure 176: MEA Market Value (US$ Million) by Type, 2023 to 2033 Figure 177: MEA Market Value (US$ Million) by Diagnosis, 2023 to 2033 Figure 178: MEA Market Value (US$ Million) by Surgery Type , 2023 to 2033 Figure 179: MEA Market Value (US$ Million) by End-use, 2023 to 2033 Figure 180: MEA Market Value (US$ Million) by Country, 2023 to 2033 Figure 181: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 184: MEA Market Value (US$ Million) Analysis by Type, 2018 to 2033 Figure 185: MEA Market Value Share (%) and BPS Analysis by Type, 2023 to 2033 Figure 186: MEA Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033 Figure 187: MEA Market Value (US$ Million) Analysis by Diagnosis, 2018 to 2033 Figure 188: MEA Market Value Share (%) and BPS Analysis by Diagnosis, 2023 to 2033 Figure 189: MEA Market Y-o-Y Growth (%) Projections by Diagnosis, 2023 to 2033 Figure 190: MEA Market Value (US$ Million) Analysis by Surgery Type , 2018 to 2033 Figure 191: MEA Market Value Share (%) and BPS Analysis by Surgery Type , 2023 to 2033 Figure 192: MEA Market Y-o-Y Growth (%) Projections by Surgery Type , 2023 to 2033 Figure 193: MEA Market Value (US$ Million) Analysis by End-use, 2018 to 2033 Figure 194: MEA Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033 Figure 195: MEA Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033 Figure 196: MEA Market Attractiveness by Type, 2023 to 2033 Figure 197: MEA Market Attractiveness by Diagnosis, 2023 to 2033 Figure 198: MEA Market Attractiveness by Surgery Type , 2023 to 2033 Figure 199: MEA Market Attractiveness by End-use, 2023 to 2033 Figure 200: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports